Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Pfister

Showing results (1-10 of 194) with videos related to

Pageof 20
Sort By:
Nature Reviews. Urology|April 10, 2013
Prostate cancer: in favour of active surveillance--functional outcomes matterDavid Pfister
Aktuelle Urologie|July 26, 2019
David Pfister
Aktuelle Urologie|February 8, 2024
David Pfister
Oncology Research and Treatment|April 3, 2017
[Not Available]David Pfister
Nature Reviews. Urology|November 1, 2016
Prostate cancer: Estimated life expectancy: integration of age and comorbiditiesAxel Heidenreich, David Pfister
Archivos Espanoles De Urologia|March 15, 2012
Management of patients with clinical stage I nonseminomatous testicular germ cell tumours: active surveillance versus primary chemotherapy versus nerve sparing retroperitoneal lymphadenectomyAxel Heidenreich, David Pfister
Nature Reviews. Urology|April 15, 2015
Prostate cancer: Sequencing AR-targeted agents might be ineffective in mCRPCAxel Heidenreich, David Pfister
Journal of Chromatography. A|December 16, 2014
Mass transfer coefficients determination from linear gradient elution experimentsDavid Pfister, Massimo Morbidelli
BJU International|October 25, 2019
PSA persistence after radical prostatectomy needs more than standard therapeutic options to improve outcomesAxel Heidenreich, David Pfister
Aktuelle Urologie|May 29, 2020
[Bladder cancer - complications related to urinary diversion]David Pfister, Günter Niegisch
Pageof 20

Showing results (1-10 of 194) with videos related to

Sort By:
Pageof 20
Nature Reviews. Urology|April 10, 2013
Prostate cancer: in favour of active surveillance--functional outcomes matterDavid Pfister
Aktuelle Urologie|July 26, 2019
David Pfister
Aktuelle Urologie|February 8, 2024
David Pfister
Oncology Research and Treatment|April 3, 2017
[Not Available]David Pfister
Nature Reviews. Urology|November 1, 2016
Prostate cancer: Estimated life expectancy: integration of age and comorbiditiesAxel Heidenreich, David Pfister
Archivos Espanoles De Urologia|March 15, 2012
Management of patients with clinical stage I nonseminomatous testicular germ cell tumours: active surveillance versus primary chemotherapy versus nerve sparing retroperitoneal lymphadenectomyAxel Heidenreich, David Pfister
Nature Reviews. Urology|April 15, 2015
Prostate cancer: Sequencing AR-targeted agents might be ineffective in mCRPCAxel Heidenreich, David Pfister
Journal of Chromatography. A|December 16, 2014
Mass transfer coefficients determination from linear gradient elution experimentsDavid Pfister, Massimo Morbidelli
BJU International|October 25, 2019
PSA persistence after radical prostatectomy needs more than standard therapeutic options to improve outcomesAxel Heidenreich, David Pfister
Aktuelle Urologie|May 29, 2020
[Bladder cancer - complications related to urinary diversion]David Pfister, Günter Niegisch
Pageof 20